Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Disruptions
Behind the steady rise in attention based care, a quieter set of structural barriers is reshaping outcomes for patients and companies. The attention deficit hyperactivity disorder (ADHD) therapeutics market disruptions are emerging not from demand shortages but from diagnostic inconsistencies and fragmented treatment pathways.
What makes this shift more complex is how attention deficit...